Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Link Pharma ChemBOM:524748 61 PS Ratio is 0.45 as of Aug. 27, 2026, which is 5% above its 10-year median of 0.43. GuruFocus rates BOM:524748 with a GF Score™ of 61/100 and a GF Value™ of ₹36.75 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,578 Chemicals companies, Link Pharma Chem ranks better than 85.23% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Link Pharma Chem's share price is ₹28.00.
Link Pharma Chem's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹61.58. Hence, Link Pharma Chem's PS Ratio for today is 0.45.
The historical rank and industry rank for Link Pharma Chem's PS Ratio or its related term are showing as below:
BOM:524748'
s PS Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.43 Max: 0.89
Current: 0.46
During the past 13 years, Link Pharma Chem's highest PS Ratio was 0.89. The lowest was 0.19. And the median was 0.43.
BOM:524748's PS Ratio is ranked better than 85.23% of 1578
companies
in the Chemicals industry
Industry Median: 1.42
vs BOM:524748: 0.46
Link Pharma Chem Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Link Pharma Chem was 11.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -10.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -10.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.70% per year.
During the past 13 years, Link Pharma Chem's highest 3-Year average Revenue per Share Growth Rate was 29.80% per year. The lowest was -22.00% per year. And the median was 12.00% per year.
Link Pharma Chem (BOM:524748) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Link Pharma Chem PS Ratio Related Terms
Link Pharma Chem PS Ratio Historical Data
* Premium members only.
The historical data trend for Link Pharma Chem's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Link Pharma Chem's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Link Pharma Chem PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Link Pharma Chem's PS Ratio distribution charts can be found below:
* The bar in red indicates where Link Pharma Chem's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Link Pharma Chem's Share Price of today is ₹28.00. Link Pharma Chem's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹61.58.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Link Pharma Chem (BOM:524748) has a PS Ratio of 0.45 as of Aug. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Link Pharma Chem and its competitors. This is near median its historical median of 0.43. Over the past decade, Link Pharma Chem's PS Ratio has ranged from 0.19 to 0.89. According to the industry distribution chart, Link Pharma Chem ranks #233 out of 1578 companies in the Chemicals industry, placing it in the top 14.8%.
Is Link Pharma Chem's PS Ratio too high?
Link Pharma Chem's current PS Ratio of 0.45 is near median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 0.89. The Chemicals industry median PS Ratio is 1.42. Link Pharma Chem's value of 0.45 is 68.3% below this industry median. Based on the distribution chart, Link Pharma Chem ranks #233 out of 1578 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Link Pharma Chem has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Link Pharma Chem's PS Ratio compare to DOW?
According to the Chemicals industry distribution chart, Link Pharma Chem ranks #233 out of 1578 companies for PS Ratio. This places Link Pharma Chem in the top 15% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.42. Link Pharma Chem's value of 0.45 is 68.3% below this benchmark. Historically, Link Pharma Chem's own PS Ratio has ranged from 0.19 to 0.89 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 1.42, Link Pharma Chem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Chemicals company?
The median PS Ratio among Chemicals companies is 1.42, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Link Pharma Chem's current PS Ratio of 0.45 is 68.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Link Pharma Chem and its competitors. For the Chemicals industry, the median PS Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Link Pharma Chem's current PS Ratio is 0.45, which is near median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Link Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Link Pharma Chem (BOM:524748) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹36.75, compared to a current price of ₹28.00 — trading 23.8% below its estimated fair value. The current PS Ratio is 0.45, which is near median its 10-year median of 0.43 and 68.3% below the Chemicals industry median of 1.42. Link Pharma Chem's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Link Pharma Chem (BOM:524748), the current PS Ratio is 0.45 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Link Pharma Chem (BOM:524748) Overvalued in 2026?
Based on GuruFocus' analysis, Link Pharma Chem stock appears to be undervalued.
The current stock price of ₹28.00 is trading 23.8% below its estimated GF Value™ of ₹36.75.
GuruFocus considers Link Pharma Chem to be Modestly Undervalued.
Key valuation signals for BOM:524748:
PS Ratio: 0.45 (near median its 10-year median of 0.43)
GF Value™: ₹36.75 vs. price of ₹28.00 (23.8% below fair value)
Industry Position: 68.3% below the Chemicals median (#233 of 1578)
No single metric tells the full story. See the BOM:524748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Link Pharma Chem Ltd is engaged in the manufacturing and selling of organic intermediates which are used in pharmaceuticals, agro and speciality chemical industries. The company has its manufacturing location at Nandesari in Gujarat. It operates through single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.
61GF Score
Get the complete analysis for BOM:524748
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524748 has been successfully added to your 
